These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 966144)

  • 21. Depot fluphenazine enanthate and decanoate: comparative rates of release in dogs.
    Dreyfuss J; Ross JJ; Shaw JM; Miller I; Schreiber EC
    J Pharm Pharmacol; 1975 Oct; 27(10):791-2. PubMed ID: 241800
    [No Abstract]   [Full Text] [Related]  

  • 22. Depot fluphenazine decanoate and enanthate for schizophrenia.
    David A; Adams CE; Eisenbruch M; Quraishi S; Rathbone J
    Cochrane Database Syst Rev; 2005 Jan; (1):CD000307. PubMed ID: 15674872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Excretion and metabolism of intramuscularly administered [14C]-haloperidol decanoate in rats.
    Matsunaga Y; Nambu K; Oh-e Y; Miyazaki H; Hashimoto M
    Arzneimittelforschung; 1986 Mar; 36(3):453-6. PubMed ID: 3707664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pharmacokinetics of nitrendipine. I. Absorption, plasma concentrations, and excretion after single administration of [14C]nitrendipine to rats and dogs.
    Krause HP; Ahr HJ; Beermann D; Siefert HM; Suwelack D; Weber H
    Arzneimittelforschung; 1988 Nov; 38(11):1593-9. PubMed ID: 3214442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disposition of [14C]aztreonam in rats, dogs, and monkeys.
    Kripalani KJ; Singhvi SM; Weinstein SH; Everett DW; Bathala MS; Dean AV; Ita CE; Lawrence L; Meeker FS; Shaw JM
    Antimicrob Agents Chemother; 1984 Aug; 26(2):119-26. PubMed ID: 6541449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacological studies of long-acting phenothiazines with particular reference to fluphenazine decanoate (author's transl)].
    Chen PC
    Nihon Yakurigaku Zasshi; 1978 Oct; 74(7):871-83. PubMed ID: 570538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105.
    Mukai H; Sugimoto T; Ago M; Morino A
    Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disposition of decabromobiphenyl ether in rats dosed intravenously or by feeding.
    el Dareer SM; Kalin JR; Tillery KF; Hill DL
    J Toxicol Environ Health; 1987; 22(4):405-15. PubMed ID: 3694703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluphenazine decanoate and fluphenazine enanthate in the out-patient management of chronic schizophrenia.
    MacCrimmon DJ; Saxena B; Foley P; Grof P
    Neuropsychobiology; 1978; 4(6):360-5. PubMed ID: 692838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The absorption and excretion of the peripheral vasodilator 14C-mecinarone, (14C-6809 MD) in rat, dog and man.
    Hawkins DR; Weston KT; Chasseaud LF; Darragh A; O'Kelly A
    Eur J Drug Metab Pharmacokinet; 1980; 5(3):135-43. PubMed ID: 7202431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absorption of intramuscularly administered [14C]haloperidol decanoate in rats.
    Matsunaga Y; Nambu K; Oh-e Y; Miyazaki H; Hashimoto M
    Eur J Drug Metab Pharmacokinet; 1987; 12(3):175-81. PubMed ID: 3436339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
    Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
    Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of Sch 34343 in rats and dogs.
    Lin C; Loebenberg D; Chung M; Oden E; Veals J; Kim H; Lim J; Korduba C; D'Souza R; Moss E
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():219-26. PubMed ID: 4030549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
    Okuyama Y; Momota K; Morino A
    Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolism of 8-(methylthio)cyclic 3',5'-adenosine monophosphate by rats and dogs after oral or intravenous dosing and in vitro by subcellular preparations of dog liver.
    Dreyfuss J; Shaw JM; Wong KK; Schreiber EC
    J Pharm Sci; 1975 Oct; 64(10):1604-12. PubMed ID: 171373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monitoring plasma levels of fluphenazine during chronic therapy with fluphenazine decanoate.
    Miller RS; Peterson GM; McLean S; Westhead TT; Gillies P
    J Clin Pharm Ther; 1995 Apr; 20(2):55-62. PubMed ID: 7650075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of 1050 mg fluphenazine decanoate given intramuscularly over six days.
    Cheung HK; Yu EC
    Br Med J (Clin Res Ed); 1983 Mar; 286(6370):1016-7. PubMed ID: 6403175
    [No Abstract]   [Full Text] [Related]  

  • 38. Study of accumulation of fluphenazine enanthate and fluphenazine decanoate, long-acting neuroleptic drugs, after repeated administrations by means of their inhibitory effects on the discriminated avoidance response in rats.
    Kuribara H; Tadokoro S
    J Toxicol Sci; 1979 May; 4(2):87-98. PubMed ID: 501762
    [No Abstract]   [Full Text] [Related]  

  • 39. Disposition of 2-(2-quinolyl)-1,3-indandione (D. C. yellow #11) in rats dosed orally or intravenously.
    el Dareer SM; Kalin JR; Tillery KF; Hill DL
    J Toxicol Environ Health; 1988; 23(3):385-93. PubMed ID: 3351983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute intravenous and inhalation pharmacokinetics of 2,4-pentanedione in the Fischer 344 rat.
    Frantz SW; Ballantyne B; Leung HW
    Toxicol Ind Health; 1998; 14(3):413-28. PubMed ID: 9569447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.